Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Health Chat for lifestyle planning in people with multiple cardiometabolic conditions

Official title: Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity (HcELP_CMM) Program: a Randomized Controlled Trial Study

Run by The University of Hong Kong · NCT07158697 · Data updated 2026-11-12

This program tests whether a 12-week face-to-face and WeChat-based Health Chat can help adults with two or more cardiometabolic conditions improve lifestyle habits and health.

More Multimorbidity trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment232 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations3 sites (Suzhou, Jiangsu and 2 other locations)
StatusRecruiting
StartedSeptember 8, 2025
Main results expectedFebruary 5, 2027
Study endsFebruary 5, 2027
Registry record updatedMay 11, 2026
Trial IDNCT07158697 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with two or more cardiometabolic conditions (for example hypertension, type 2 diabetes, stroke, heart disease, dyslipidemia, or obesity) who can use WeChat and attend community health centers in Suzhou.

Probably not a fit

People with contraindications to exercise (severe musculoskeletal or cardiovascular disease), serious psychiatric illness, significant cognitive impairment, sensory or communication barriers, or without a WeChat-capable device are unlikely to be eligible or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This two-part project uses a single-blind, parallel-group, randomized design comparing a 12-week Health Chat empowerment program to usual care in adults with cardiometabolic multimorbidity. The intervention combines an individualized, one-hour face-to-face goal-oriented counseling session with a subsequent WeChat-based personalized lifestyle empowerment program that includes goal setting and measurable biofeedback. Part 1 is a mixed-method pilot (randomized trial followed by qualitative interviews) and Part 2 is a full randomized controlled trial, with participants randomized 1:1 to intervention or usual care. Primary outcomes include feasibility and acceptability, with short- and long-term measures of lifestyle behaviors, cardiometabolic indicators, symptom burden, health-related quality of life, psychological well-being, and physical function.

Why it matters

Potential benefit: If successful, the program could help people with multiple cardiometabolic conditions adopt and sustain healthier behaviors, improve cardiometabolic risk markers, reduce symptoms, and enhance quality of life.

How similar studies have gone: Related digital coaching and empowerment programs have shown modest short-term improvements in lifestyle behaviors and cardiometabolic risk in other populations, but tailored empowerment interventions for cardiometabolic multimorbidity remain relatively novel with mixed evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged 18 years or above;
2. Diagnosed with cardiometabolic multimorbidity (CMM), which was defined as co-existing with two or more cardiometabolic diseases, including primary hypertension, type 2 diabetes, stroke, heart diseases (eg. coronary heart disease, arrhythmia, heart failure, myocardial infarction, and cardiac valve diseases), dyslipidemia, and obesity;
3. Possessed a digital device installed with WeChat, as well as with an internet connection.

Exclusion Criteria:

1. Contraindications to exercise according to American College of Sports Medicine (ACSM), such as severe musculoskeletal disorders, severe cardiovascular diseases, or spinal nerve injury;
2. Diagnosis of psychiatric disease;
3. Has impaired cognitive function as indicated by an Abbreviated Mental Test Score (AMTS) ≤6;
4. Has impaired sensory or communication function which hider them participation in this program, such as hearing loss, vision loss, and unable to speak Mandarin.

Where it's running

  • Gusu District Feng Men Street Community Health Service Center
    Suzhou, Jiangsu, China
    Recruiting
  • Gusu District Jinchang Street Bailian Community Health Service Center
    Suzhou, Jiangsu, China
    Recruiting
  • Gusu District Shuang Ta Street Jinfan Community Health Service Center
    Suzhou, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.